Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Phaos Technology Holdings Cayman EV-to-EBITDA?
Phaos Technology Holdings CaymanPOAS -6.08%4 EV-to-EBITDA is -1.10 as of Jul. 26, 2026. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 511 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 195694.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Phaos Technology Holdings Cayman's enterprise value is $3.71 Mil.
Phaos Technology Holdings Cayman's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was $-3.38 Mil. Therefore, Phaos Technology Holdings Cayman's EV-to-EBITDA for today is -1.10.
The historical rank and industry rank for Phaos Technology Holdings Cayman's EV-to-EBITDA or its related term are showing as below:
POAS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -21.47 Med: -6.79 Max: -0.8
Current: -1.1
During the past 3 years, the highest EV-to-EBITDA of Phaos Technology Holdings Cayman was -0.80. The lowest was -21.47. And the median was -6.79.
POAS's EV-to-EBITDA is ranked worse than 100% of 511
companies
in the Medical Devices & Instruments industry
Industry Median: 14.03
vs POAS: -1.10
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phaos Technology Holdings Cayman's PE Ratio (TTM) for today is calculated as:
Phaos Technology Holdings Cayman's share price for today is $0.2208.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.264.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's EV-to-EBITDA falls into.
Phaos Technology Holdings Cayman's current Enterprise Value is $3.71 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was $-3.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman (POAS) has a EV-to-EBITDA of -1.10 as of Jul. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Phaos Technology Holdings Cayman. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 511 companies in the Medical Devices & Instruments industry.
Is Phaos Technology Holdings Cayman's EV-to-EBITDA too high?
Phaos Technology Holdings Cayman's current EV-to-EBITDA is -1.10. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 511 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's EV-to-EBITDA compare to WOK and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #999999 out of 511 companies for EV-to-EBITDA. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median EV-to-EBITDA is 14.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.03, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Phaos Technology Holdings Cayman. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current EV-to-EBITDA is -1.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current EV-to-EBITDA of -1.10. The current EV-to-EBITDA is -1.10. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current EV-to-EBITDA is -1.10 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Business Description
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score
Get the complete analysis for POAS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
